Evidence mapPaperPMID 39269286Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Needle-Plug/Piston-Based Modular Mesoscopic Design Paradigm Coupled With Microfluidic Device for Point-of-Care Pooled Testing.

Baobao Lin, Bao Li, Wu Zeng, Yulan Zhao, Huiping Li, Yin Gu, Peng Liu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. [Preclinical Development Process and Prospects of Real-time Fluorescence Quantitative Polymerase Chain Reaction Detection Kits].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Baobao LinDepartment of Biomedical Engineering, Tsinghua University, Beijing, 100084, China.
Bao LiDepartment of Biomedical Engineering, Tsinghua University, Beijing, 100084, China.
Wu ZengDepartment of Biomedical Engineering, Tsinghua University, Beijing, 100084, China.
Yulan ZhaoChangping Laboratory, Beijing, 102206, China.
Huiping LiDepartment of Biomedical Engineering, Tsinghua University, Beijing, 100084, China.
Yin GuState Key Laboratory of Space Medicine, China Astronaut Research and Training Center, Beijing, 100094, China.
Peng LiuDepartment of Biomedical Engineering, Tsinghua University, Beijing, 100084, China.ORCID 0000-0003-3000-3168

Funding

National Key Research and Development Program of China 2022YFC2704902National Natural Science Foundation of China 32001021
6 · The paper itself

Abstract

Emerging diagnostic scenarios, such as population surveillance by pooled testing and on-site rapid diagnosis, highlight the importance of advanced microfluidic systems for in vitro diagnostics. However, the widespread adoption of microfluidic technology faces challenges due to the lack of standardized design paradigms, posing difficulties in managing macro-micro fluidic interfaces, reagent storage, and complex macrofluidic operations. This paper introduces a novel modular-based mesoscopic design paradigm, featuring a core "needle-plug/piston" structure with versatile variants for complex fluidic operations. These structures can be easily coupled with various microfluidic platforms to achieve truly self-contained microsystems. Incorporated into a "3D extensible" design architecture, the mesoscopic design meets the demands of function integration, macrofluid manipulations, and flexible throughputs for point-of-care nucleic acid testing. Using this approach, an ultra-sensitive nucleic acid detection system is developed with a limit of detection of ten copies of SARS-CoV-2 per mL. This system efficiently conducts large-scale pooled testing from 50 pharyngeal swabs in a tube with an uncompromised sensitivity, enabling a truly "sample-in-answer-out" microsystem with exceptional performance.

Indexed as

COVID-19Equipment DesignLab-On-A-Chip DevicesPoint-of-Care TestingCOVID-19 Nucleic Acid TestingHumansMicrofluidic Analytical TechniquesPoint-of-Care SystemsSARS-CoV-2microfluidicsmodular designpoint‐of‐care testing

Identifiers

PMID39269286
PMCPMC11558091

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.